Aurora Cannabis Inc (NYSE:ACB) traded down 6.3% on Tuesday . The stock traded as low as $4.72 and last traded at $4.76, 17,748,653 shares changed hands during mid-day trading. An increase of 24% from the average session volume of 14,259,826 shares. The stock had previously closed at $5.08.
Several equities research analysts recently weighed in on the stock. LADENBURG THALM/SH SH assumed coverage on shares of Aurora Cannabis in a research note on Wednesday, July 17th. They issued a “buy” rating and a $9.00 target price for the company. Compass Point set a $8.00 target price on shares of Aurora Cannabis and gave the company a “hold” rating in a research note on Thursday, September 12th. MKM Partners cut shares of Aurora Cannabis to a “sell” rating in a research note on Friday. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Wednesday, August 21st. Finally, Zacks Investment Research upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Thursday, September 12th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $8.09.
The company has a quick ratio of 1.14, a current ratio of 1.52 and a debt-to-equity ratio of 0.09. The stock has a market cap of $4.86 billion, a price-to-earnings ratio of -21.64 and a beta of 2.47. The company’s 50-day moving average is $5.83 and its 200-day moving average is $7.54.
About Aurora Cannabis (NYSE:ACB)
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Read More: Moving Average Convergence Divergence (MACD)
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.